Skip to main content
Clinical Trials/NCT06028061
NCT06028061CompletedNot Applicable

Evaluation of The Postoperative Analgesic Effectivity of Quadratus Lumborum Block III With Adjuvant on Patients Undergoing Laparoscopic Cholecystectomy Surgery : A Randomised Controled Study

Gaziosmanpasa Research and Education Hospital2 sites in 2 countries83 target enrollmentStarted: September 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
83
Locations
2
Primary Endpoint
Total amount of opioid requirements

Study Overview

Brief Summary

İn recent years abdominal wall blocks are widely used for to reduce intraoperative anesthetic recuirements and postoperative analgesia.Quadratus lumborum blocks are one of the abdominal wall blocks to used at laparoscopic cholecystectomy.Conventionally adjuvants used to improve and prolonged the effect of periferic nerve, spinal and abdominal blocks.İn this study investigators will evaluate the effectiveness of adjuvants at quatratus lumborum block at patient underwent laparoscopic cholecystectomy.

Detailed Description

Laparoscopic approach in cholecystectomy surgery is frequently preferred because of its advantages in systemic complications, morbidity, mortality and hospital stay. Pain is one of the important causes of late discharge after surgery. Laparoscopic cholecystectomy surgery requires a multimodal analgesia approach because of its multiple pain components.Regional analgesia techniques are effective in reducing the side effects such as intraoperative opioid use, postoperative pain and nausea and vomiting. Quadratus lumborum III block is a regional technique performed for multimodal analgesia.Adjuvants are known to improve the analgesic efficacy and prolonge the effect of the periferic and central nerve blocks.The aim of this study is to determine the effectiveness of adding adjuvant at quadratus lumborum block for patients who underwent laparoscopic cholecystectomy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • American Society of Anesthesiologists physical statusⅠ-II

Exclusion Criteria

  • Inclusion Criteria:
  • 18-65 years of age
  • American Society of Anesthesiologists physical statusⅠ-II
  • Exclusion Criteria:
  • local anesthetic allergy
  • Infection at the procedure site Body Mass Index >35 kg/m2 Anticoagulant use with bleeding disorder Chronic analgesia and opioid use with mental and psychiatric disorders Contraindications to regional anesthesia several lung and heart disease

Outcomes

Primary Outcomes

Total amount of opioid requirements

Time Frame: within 24 hours after the surgery

The total tramadol use of the patients in 24 hours will be recorded.

rescue analgesia

Time Frame: within 24 hours after the surgery

The rescue analgesia requirement and time of the need of the rescue analgesia requirement

Secondary Outcomes

  • intraoperative remifentanil consumption(during operation procedure])
  • side effects such as nausea, vomiting and shoulder pain(within 24 hours after the surgery)
  • Visual Analogue Scale values(at 1st, 4th,8th 12th and 24th hours after the surgery])

Investigators

Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

SERPİL ŞEHİRLİOĞLU

MD

Gaziosmanpasa Research and Education Hospital

Study Sites (2)

Loading locations...

Similar Trials